Integrative Health Technologies, Inc. (IHTI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2009 | -26.95 Thousand USD | 0.0% |
| 2006 | 91.84 Thousand USD | -85.01% |
| 2005 | 612.8 Thousand USD | -8.48% |
| 2004 | 669.6 Thousand USD | 167.84% |
| 2003 | 250 Thousand USD | 0.0% |
| 2002 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2009 FY | -26.95 Thousand USD | 0.0% |
| 2007 Q1 | 175.13 Thousand USD | 90.69% |
| 2007 Q2 | -10.85 Thousand USD | -106.2% |
| 2007 Q3 | -10.85 Thousand USD | 0.0% |
| 2006 Q4 | 91.84 Thousand USD | 407.58% |
| 2006 Q2 | 299.88 Thousand USD | -51.12% |
| 2006 Q1 | 613.5 Thousand USD | 0.11% |
| 2006 FY | 91.84 Thousand USD | -85.01% |
| 2006 Q3 | -29.86 Thousand USD | -109.96% |
| 2005 FY | 612.8 Thousand USD | -8.48% |
| 2005 Q4 | 612.8 Thousand USD | 106.6% |
| 2005 Q2 | 614.4 Thousand USD | 87.11% |
| 2005 Q1 | 328.37 Thousand USD | -50.96% |
| 2005 Q3 | 296.61 Thousand USD | -51.72% |
| 2004 Q2 | 607.09 Thousand USD | 30.67% |
| 2004 Q3 | 696.23 Thousand USD | 14.68% |
| 2004 FY | 669.6 Thousand USD | 167.84% |
| 2004 Q4 | 669.6 Thousand USD | -3.83% |
| 2004 Q1 | 464.61 Thousand USD | 85.84% |
| 2003 Q1 | - USD | 0.0% |
| 2003 FY | 250 Thousand USD | 0.0% |
| 2003 Q4 | 250 Thousand USD | 1767.2% |
| 2003 Q3 | 13.38 Thousand USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | 101.222% |
| Arrayit Corporation | 1.05 Million USD | 102.553% |
| Atlantic International Corp. | 236.49 Thousand USD | 111.396% |
| Biocept, Inc. | -788 Thousand USD | 96.58% |
| Bioqual, Inc. | -12 Million USD | 99.776% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | 218.528% |
| DermTech, Inc. | 17.65 Million USD | 100.153% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 99.995% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 99.635% |
| iMD Companies, Inc. | 1.11 Million USD | 102.415% |
| IDenta Corp. | 524.85 Thousand USD | 105.135% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 100.35% |
| InVitro International | -313.14 Thousand USD | 91.393% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | 101.721% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | -3680.084% |
| Medical Imaging Corp. | 3.79 Million USD | 100.711% |
| NovelStem International Corp. | 3.52 Million USD | 100.765% |
| Optigenex Inc. | 8.93 Million USD | 100.302% |
| PharmChem, Inc. | -1.49 Million USD | 98.196% |
| Proteome Sciences plc | 14.57 Million USD | 100.185% |
| Response Genetics, Inc | -13.08 Million USD | 99.794% |
| Rennova Health, Inc. | 14.82 Million USD | 100.182% |
| RushNet, Inc. | 4.8 Million USD | 100.561% |
| ScreenPro Security Inc. | 135.58 Thousand USD | 119.878% |
| Stella Diagnostics Inc. | 6.19 Million USD | 100.435% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | 101.51% |
| Todos Medical Ltd. | 38.31 Million USD | 100.07% |